You will have a full screening with a provider before beginning our comprehensive weight loss program
Sources MOUNJARO (tirzepatide) Injection, for subcutaneous use (2022) Zepbound (tirzepatide) Injection, for subcutaneous use (2022) Tirzepatide Once Weekly for the Treatment of Obesity (June 4, 2022) Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (May 11, 2025)
This blog delves into the potential risks and benefits of glutathione, exploring whether its use could lead to skin cancer
This does not mean MT2 has 'stopped working'
Whether you are exploring cosmetic injectables, skin rejuvenation treatments, wellness therapies, or hair restoration, we are here to guide you with expert care in a warm and welcoming environment